Diagnostic tools are critical to keep everyone safe and track newly emerging variants
Data since 2015
71
clinical trials
undertaken
11
WHO recommendations supported
6,000+
health workers trained
32,500+
patients enrolled in studies
50m+
FIND-supported
products procured
3,000+
laboratories & testing
sites strengthened
New FIND partnerships make COVID-19 rapid tests available to refugees and internally displaced people in the Middle East
ReadSupport package including US$7 million investment accelerates availability of affordable COVID-19 self-tests in low- and middle-income countries
ReadAERAP Science, FIND and The Lancet Commission on diagnostics join with partners to call on decision-makers at the 6th EU-AU Summit to address urgent diagnostic gaps in support of universal health coverage
ReadZaza is a social worker at Imedi HRS in Batumi, Georgia. With a lab specialist, Zaza does community outreach work conducting mobile counseling and screening for hepatitis C and other infectious diseases, using a lab-in-a van.
Read
Meet Sabir. He is 14 years old and lives in Surat, India. He loves studying and competed in the national Science Olympiad. He found out he had TB only after learning about the disease during a school visit by doctors.
Read
This is Jennifer from the Research Institute for Tropical Medicine (RITM) in the Philippines, leading a workshop in Addis Ababa, Ethiopia, on quality testing for malaria rapid tests.
Read
12 May 2022 – Today, President Biden will emphasize “global test to treat” as world leaders and distinguished guests convene at the second Global COVID-19 Summit, hosted by the Governments of Belize, Germany, Indonesia, Senegal, and the United States. The Summit will focus on recommitting intensity to the global response; vaccinating the world; protecting the most vulnerable; and preventing future catastrophes. l have the privilege to be moderating a session…
Read moretest
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aliquam aspernatur, at blanditiis culpa ea et expedita iure iusto laboriosam laborum maiores minima modi nostrum nulla officia quibusdam repellendus suscipit voluptatibus!
test tes test test test ttdfs
R&D
Clinical trials
Access
Geneva, Switzerland (HQ)
Hanoi, Viet Nam
New Delhi, India
Cape Town, South Africa
Nairobi, Kenya
